155 related articles for article (PubMed ID: 17464317)
1. Expression of MYCN in pediatric synovial sarcoma.
Somers GR; Zielenska M; Abdullah S; Sherman C; Chan S; Thorner PS
Mod Pathol; 2007 Jul; 20(7):734-41. PubMed ID: 17464317
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of synovial sarcoma with the reverse transcriptase-polymerase chain reaction: analyses of 84 soft tissue and bone tumors.
Hiraga H; Nojima T; Abe S; Sawa H; Yamashiro K; Yamawaki S; Kaneda K; Nagashima K
Diagn Mol Pathol; 1998 Apr; 7(2):102-10. PubMed ID: 9785009
[TBL] [Abstract][Full Text] [Related]
3. Correlation of MYCN amplification with MCM7 protein expression in neuroblastomas: a chromogenic in situ hybridization study in paraffin sections.
Tsai HY; Hsi BL; Hung IJ; Yang CP; Lin JN; Chen JC; Tsai SF; Huang SF
Hum Pathol; 2004 Nov; 35(11):1397-403. PubMed ID: 15668898
[TBL] [Abstract][Full Text] [Related]
4. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma.
Olsen SH; Thomas DG; Lucas DR
Mod Pathol; 2006 May; 19(5):659-68. PubMed ID: 16528378
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study.
Ito J; Asano N; Kawai A; Yoshida A
Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417
[TBL] [Abstract][Full Text] [Related]
6. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors.
Folpe AL; Schmidt RA; Chapman D; Gown AM
Am J Surg Pathol; 1998 Jun; 22(6):673-82. PubMed ID: 9630174
[TBL] [Abstract][Full Text] [Related]
7. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
[TBL] [Abstract][Full Text] [Related]
8. HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of HMGA2 in malignant peripheral nerve sheath tumor.
Hui P; Li N; Johnson C; De Wever I; Sciot R; Manfioletti G; Tallini G
Mod Pathol; 2005 Nov; 18(11):1519-26. PubMed ID: 16056249
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation.
Allander SV; Illei PB; Chen Y; Antonescu CR; Bittner M; Ladanyi M; Meltzer PS
Am J Pathol; 2002 Nov; 161(5):1587-95. PubMed ID: 12414507
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of MYCN and ID2 overexpression in neuroblastoma.
Alaminos M; Gerald WL; Cheung NK
Pediatr Blood Cancer; 2005 Dec; 45(7):909-15. PubMed ID: 16047351
[TBL] [Abstract][Full Text] [Related]
11. Primary pulmonary and mediastinal synovial sarcoma: a clinicopathologic study of 60 cases and comparison with five prior series.
Hartel PH; Fanburg-Smith JC; Frazier AA; Galvin JR; Lichy JH; Shilo K; Franks TJ
Mod Pathol; 2007 Jul; 20(7):760-9. PubMed ID: 17464314
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnosis of synovial sarcoma: RT-PCR detection of SYT-SSX1/2 fusion transcripts in paraffin-embedded tissue.
Tvrdík D; Povýsil C; Svatosová J; Dundr P
Med Sci Monit; 2005 Mar; 11(3):MT1-7. PubMed ID: 15735574
[TBL] [Abstract][Full Text] [Related]
13. Multicolor fluorescence in situ hybridization analysis of a synovial sarcoma of the larynx with a t(X;18)(p11.2;q11.2) and trisomies 2 and 8.
Szuhai K; Knijnenburg J; Ijszenga M; Tanke HJ; Baatenburg de Jong RJ; Bas Douwes Dekker P; Rosenberg C; Hogendoorn PC
Cancer Genet Cytogenet; 2004 Aug; 153(1):48-52. PubMed ID: 15325093
[TBL] [Abstract][Full Text] [Related]
14. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
[TBL] [Abstract][Full Text] [Related]
16. Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study.
O'Sullivan MJ; Kyriakos M; Zhu X; Wick MR; Swanson PE; Dehner LP; Humphrey PA; Pfeifer JD
Mod Pathol; 2000 Nov; 13(11):1253-63. PubMed ID: 11106084
[TBL] [Abstract][Full Text] [Related]
17. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
[TBL] [Abstract][Full Text] [Related]
18. The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma.
Ishida M; Miyamoto M; Naitoh S; Tatsuda D; Hasegawa T; Nemoto T; Yokozeki H; Nishioka K; Matsukage A; Ohki M; Ohta T
Mol Cell Biol; 2007 Feb; 27(4):1348-55. PubMed ID: 17101797
[TBL] [Abstract][Full Text] [Related]
19. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.
Amary MF; Berisha F; Bernardi Fdel C; Herbert A; James M; Reis-Filho JS; Fisher C; Nicholson AG; Tirabosco R; Diss TC; Flanagan AM
Mod Pathol; 2007 Apr; 20(4):482-96. PubMed ID: 17334349
[TBL] [Abstract][Full Text] [Related]
20. [Demonstration of SYT-SSX11/2 fusion transcripts in synovial sarcomas using RT-PCR].
Willeke F; Mechtersheimer G; Schwarzbach M; Weitz J; Lehnert T; Herfarth C; Otto HF; von Knebel Doeberitz M; Ridder R
Verh Dtsch Ges Pathol; 1998; 82():215-9. PubMed ID: 10095437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
